X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
cardiac & cardiovascular systems (15) 15
humans (13) 13
abridged index medicus (12) 12
cholesterol (12) 12
cardiovascular (10) 10
cardiovascular disease (10) 10
pcsk9 (10) 10
alirocumab (9) 9
middle aged (9) 9
double-blind method (8) 8
female (8) 8
heart attacks (8) 8
hypercholesterolemia - drug therapy (8) 8
male (8) 8
mortality (8) 8
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (7) 7
statins (7) 7
therapy (7) 7
acute coronary syndrome (6) 6
acute coronary syndromes (6) 6
antibodies, monoclonal - adverse effects (6) 6
antibodies, monoclonal - therapeutic use (6) 6
atorvastatin (6) 6
cardiac and cardiovascular systems (6) 6
cholesterol, ldl - blood (6) 6
clinical medicine (6) 6
hypercholesterolemia (6) 6
kardiologi (6) 6
klinisk medicin (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
safety (6) 6
aged (5) 5
angina pectoris (5) 5
cardiology and cardiovascular medicine (5) 5
cardiovascular diseases (5) 5
diabetes (5) 5
drug therapy (5) 5
efficacy (5) 5
ezetimibe (5) 5
heart diseases (5) 5
ischemia (5) 5
lipoproteins (5) 5
monoclonal antibodies (5) 5
monoclonal-antibody (5) 5
myocardial infarction (5) 5
patients (5) 5
risk (5) 5
stroke (5) 5
treatment outcome (5) 5
analysis (4) 4
angina (4) 4
anticholesteremic agents - adverse effects (4) 4
atherosclerosis (4) 4
cerebral infarction (4) 4
confidence intervals (4) 4
coronary heart disease (4) 4
health risk assessment (4) 4
hypercholesterolemia - complications (4) 4
lipids (4) 4
low density lipoproteins (4) 4
metaanalysis (4) 4
proprotein convertase 9 (4) 4
statin therapy (4) 4
acute coronary syndrome - drug therapy (3) 3
antibodies, monoclonal - administration & dosage (3) 3
anticholesteremic agents - therapeutic use (3) 3
association (3) 3
cardiovascular diseases - prevention & control (3) 3
clinical trials (3) 3
coronary artery disease (3) 3
death (3) 3
drug dosages (3) 3
drug therapy, combination (3) 3
electrocardiography (3) 3
events (3) 3
evolocumab (3) 3
follow-up studies (3) 3
hospitalization (3) 3
hypercholesterolemia - blood (3) 3
kexin (3) 3
management (3) 3
medical services (3) 3
medicine, general & internal (3) 3
myocardial-infarction (3) 3
proprotein convertases - antagonists & inhibitors (3) 3
reducing lipids (3) 3
studies (3) 3
subtilisin (3) 3
time factors (3) 3
acute coronary syndrome - complications (2) 2
anticholesteremic agents - administration & dosage (2) 2
antilipemic agents (2) 2
apolipoprotein b (2) 2
arteriosclerosis (2) 2
azetidines - adverse effects (2) 2
biomarkers - blood (2) 2
cardiovascular risk patients (2) 2
cardiovascular-risk patients (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 906 - 915.e13
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
by Ray, Kausik K and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Diaz, Rafael and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Loizeau, Virginie and Lopes, Renato D and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Philippe Gabriel and Schwartz, Gregory G and Steg, Ph. Gabriel and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Goodman, Shaun G and Harrington, Robert A and Jukema, J. Wouter and Szarek, Michael and White, Harvey D and Zeiher, Andreas M and Tricoci, Pierluigi and Roe, Matthew T and Mahaffey, Kenneth W and Edelberg, Jay M and Hanotin, Corinne and Lecorps, Guillaume and Moryusef, Angèle and Pordy, Robert and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Lopes, Renato D and Gotcheva, Nina N and Prieto, Juan-Carlos and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Takeshi and Kim, Hyo Soo and Kim, Sang-Hyun and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Budaj, Andrzej and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Ristic, Arsen D and Chua, Terrance and Murin, Jan and Fras, Zlatko and Dalby, Anthony J and Tuñón, José and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Ray, Kausik K and Moriarty, Patrick M and Vogel, Robert and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article